Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 13, Issue -, Pages S323-S331Publisher
WILEY
DOI: 10.1111/jth.12943
Keywords
antiplatelet drugs; biomarkers; cardiovascular diseases; platelets; proteomics
Categories
Ask authors/readers for more resources
Antiplatelet agents represent the mainstay of acute coronary syndrome (ACS) therapy to prevent ischemic events and to improve safety in patients undergoing percutaneous coronary intervention. However, despite the availability of several drugs and the use of dual antiplatelet therapy, the pharmacological response is highly variable with a subset of patients continuing to experience recurrent thrombotic events, revealing a wide variability in platelet response to antiplatelet drugs. Several factors may explain this, including genetic variation and environmental factors. Here we look at the application of proteomic analysis, an approach that provides an integrated readout of these diverse influences.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available